Skip to main content
Clinical Trials/NCT04660669
NCT04660669
Not Yet Recruiting
N/A

Early Remote Intervention in Autism: a Randomized Noninferiority Clinical Trial Comparing Semi-intensive Early Start Denver Model (ESDM) Intervention With Remote Parental Training/ Supervision Versus Intensive ESDM Intervention.

University Hospital, Brest4 sites in 1 country90 target enrollmentDecember 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Early Intervention in Remote Autism
Sponsor
University Hospital, Brest
Enrollment
90
Locations
4
Primary Endpoint
The gain in developmental quotient measured using the Mullen Scales of Early Learning (MSEL)
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The Early Start Denver Model (ESDM) has shown its efficiency in the early management of ASD.

The study aims to evaluate the efficiency of a new type of management based on a semi-intensive center-based intervention (8h per week) coupled with a MOOC (Massive Online Open Course: a teaching and learning intervention based on instrumental and interactive teaching situations) for remote parental training/supervision. The goal is to determine if compared to the ESDM reference intervention (15h per week), this type of care can bring, a sufficient improvement in child development course and decreased symptoms of autism in young children, and if it could be, therefore, better suited to the needs of children and their family, bypassing the previously stated obstacles.

Registry
clinicaltrials.gov
Start Date
December 2023
End Date
December 2025
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of ASD based on the Diagnosis and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria;
  • Diagnosis of ASD on the Autism Diagnosis Observation Schedule (ADOS-2) and Autism Diagnosis Interview (ADIR) for toddlers (we will include children above or equal to 13, which is the research cut-off);
  • Aged between 15 and 36 months;
  • DQ of 30 or above at the MSEL
  • Sign informed consent form by both parents

Exclusion Criteria

  • A neurodevelopmental disorder with known etiology (e.g. fragile X syndrome, Rett syndrom)
  • Significant sensory or motor impairment
  • Major physical problems such as a chronic serious health condition
  • History of a serious head injury and/or neurologic disease
  • Seizures at time of entry
  • Use of psychoactive medications (7 ) Families unavailable for the intervention and the followup over a period of 12 months
  • (8) Impossibility for family to have access to the MOOC

Outcomes

Primary Outcomes

The gain in developmental quotient measured using the Mullen Scales of Early Learning (MSEL)

Time Frame: From day 0 to months 12

Minimum = 49 (worse outcome) and maximum = 155 (better outcome)

Secondary Outcomes

  • Assessment of child autism symptoms and change in autism symptoms using ADOS-2(At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention)
  • Assessment of child behavioral adaptation using The Vineland Adaptive Behavior Scales second version (VABS-2)(At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention)
  • Assessment of sensory reactivity using The Dunn's Sensory Profile for toddlers(At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention)
  • Assessment of the parent burden and quality of life using the CareQuol-7D(At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention)

Study Sites (4)

Loading locations...

Similar Trials